CONSENT OF INDEPENDENT AUDITORS
Published on April 17, 1997
EXHIBIT 23.1
CONSENT OF INDEPENDENT AUDITORS
We consent to the incorporation by reference in the
Registration Statement on Form S-3 of Cytoclonal Pharmaceutics Inc. (the
"Company") of our report dated February 7, 1997 (with respect to Note K[2]
February 21, 1997) relating to the balance sheet of the Company as of December
31, 1996 and the related statements of operations, changes in stockholders'
equity (capital deficiency) and cash flows for each of the years in the
two-year period ended December 31, 1996 and for the period September 11, 1991
(inception) through December 31, 1996 included in the Company's annual report on
Form 10-KSB for the fiscal year ended December 31, 1996. We also consent to the
reference to our firm under the caption "Experts" in the prospectus.
RICHARD A. EISNER COMPANY, LLP
New York, New York
April 14, 1997